Literature DB >> 6966196

Mechanisms of regulation of cell-mediated immunity: anti-I-A alloantisera interfere with induction and expression of T-cell-mediated immunity to cell-bound antigen in vivo.

L L Perry, M E Dorf, B A Bach, B Benacerraf, M I Greene.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6966196     DOI: 10.1016/0090-1229(80)90040-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  13 in total

1.  Mechanism of regulation of immune responses by in vivo administration of monoclonal anti-I-A antibodies.

Authors:  M I Greene; L Perry; A Carroll; A Lowy
Journal:  Surv Immunol Res       Date:  1985

2.  Significance and biological function of class II MHC molecules. Rous-Whipple Award lecture 1985.

Authors:  B Benacerraf
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

Review 3.  Regulation of the immune response to antigens on the malignant cell surface.

Authors:  J A Drebin; L L Perry; R Carter; M I Greene
Journal:  Springer Semin Immunopathol       Date:  1982

Review 4.  T-cell receptor and autoimmune disease.

Authors:  S Komori; R M Siegel; K Yui; M Katsumata; M I Greene
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

5.  Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes.

Authors:  L Raphael; B H Tom
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

Review 6.  Mechanisms of peripheral immune tolerance: conversion of the immune to the unresponsive phenotype.

Authors:  Sandra J Saouaf; Patrick J Brennan; Yuan Shen; Mark I Greene
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Anti-I-A antibody modulation of lymphocyte traffic in hapten-stimulated inbred mice.

Authors:  A M Carroll; M I Greene
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

8.  In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.

Authors:  J T Rosenbaum; N E Adelman; H O McDevitt
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

9.  Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.

Authors:  N E Adelman; D L Watling; H O McDevitt
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

Authors:  D Wofsy; W E Seaman
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.